Targeted Drug Delivery — From Magic Bullet to Nanomedicine: Principles, Challenges, and Future Perspectives
Ashagrachew Tewabe,Atlaw Abate,Manaye Tamrie,Abyou Seyfu,Ebrahim Abdela Siraj
DOI: https://doi.org/10.2147/JMDH.S313968
2021-07-05
Journal of Multidisciplinary Healthcare
Abstract:Ashagrachew Tewabe, 1 Atlaw Abate, 2 Manaye Tamrie, 3 Abyou Seyfu, 3 Ebrahim Abdela Siraj 1 1 Department of Pharmacy, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia; 2 Ethiopian Food and Drug Authority (EFDA), Federal Ministry of Health (FMoH), Addis Ababa, Ethiopia; 3 Department of Pharmaceutics and Social Pharmacy, School of Pharmacy, College of Health Sciences, Mizan-Tepi University, Mizan-Aman, Ethiopia Correspondence: Ashagrachew Tewabe Department of Pharmacy, College of Medicine and Health Sciences, Bahir Dar University, PO Box 79, Bahir Dar, Ethiopia Tel +251 91-296-0525 Email Nanomedicine is an advanced version of Paul Ehrlich's "magic bullet" concept. Targeted drug delivery is a system of specifying the drug moiety directly into its targeted body area (organ, cellular, and subcellular level of specific tissue) to overcome the aspecific toxic effect of conventional drug delivery, thereby reducing the amount of drug required for therapeutic efficacy. To achieve this objective, the magic bullet concept was developed and pushed scientists to investigate for more than a century, leading to the envisioning of different nanometer-sized devices — today's nanomedicine. Different carrier systems are being used and investigated, which include colloidal (vesicular and multiparticulate) carriers, polymers, and cellular/subcellular systems. This review addresses the need for and advantages of targeting, with its basic principles, strategies, and carrier systems. Recent advances, challenges, and future perspectives are also highlighted. Keywords: targeting, polymers, nanoparticles, carriers, nanosomes Drug delivery (DD) refers to the methods, formulations, technologies, and processes involved in transporting a pharmaceutical substance in the body to achieve the desired therapeutic effect. 1 It encompasses the approaches of administering medicinal compounds in humans and animals to attain therapeutic effectiveness. Recent developments in drug delivery systems (DDSs) are primarily been focused on smart DD, which focuses on drug administration at the appropriate time, dosage, and location with maximum safety and efficacy. 2 The advancement of novel DDSs (NDDSs) has attracted pronounced attention in recent years. These systems enhance the therapeutic effectiveness of new and existing drugs with targeted, managed, and sustained delivery while meeting real and appropriate drug demand. 1 DD is a growing field in pharmaceutical science. There are five generations of DDSs, and targeted delivery belongs to the fourth generation. 3 Figure 1 illustrates the generations of DDSs. Over the last few decades, developing sustained or controlled DDSs has been a focus, with the objective of controlling and/or sustaining drug release, reducing dose frequency, or increasing drug efficacy compared to conventional delivery. Bilayer tablets are one example of an NDDS, used with modification of conventional drug-preparation and -delivery approaches. They are composed of two of the same drug or different drugs fixed in a single dose for sequential release of the combined drugs or sustained and immediate release of the same drug, one as a loading dose and other as a maintenance dose. 4 Such modifications in all forms of traditional DD can represent promising advancements, but there are still types of DDSs that need to be refined, such as delivery of poorly soluble drug formulations, protein delivery, self-regulated insulin delivery, and targeted DDSs (TDDSs). Targeted delivery to tumors is another potential advance that can be achieved with nanotechnology-based DSs. 5 Nanoparticle (NP)-based DD brings an opportunity for controlled release of drugs, allowing sufficient time for drugs to act with enhanced therapeutic action and respond to specific stimuli, such as pH, light, heat, or enzymes. 6 Figure 1 Generation of drug-delivery systems. TDDSs are where a drug is delivered to a specific location, rather than the whole body or organ, and combine diverse fields of science, such as polymer science, pharmacology, bioconjugate chemistry, and molecular biology. TDD is aimed at managing and controlling the pharmacokinetics, pharmacodynamics, aspecific toxicity, immunogenicity, and biorecognition of therapeutic agents. 7 The end goal is improving treatment effectiveness while reducing side effects. TDDSs differ from conventional or traditional DDSs in that they acquire site-specific release of drugs from a dosage form -Abstract Truncated-
health care sciences & services